Women's Health Update 2026: Cardiovascular Disease and Menopause

Women's Health Update 2026: Cardiovascular Disease and Menopause is organized by Scripps Conference Services & CME and will be held from Feb 27 - 28, 2026 at The Westin Carlsbad Resort & Spa, Carlsbad, California, United States of America.

Overview:
The Scripps Women’s Health Update: Cardiovascular Disease and Menopause symposium aims to equip clinicians with the latest evidence-based insights for managing medical conditions that are unique to women or manifest differently than in men, requiring customized prevention and treatment approaches. The primary goal of this activity is to improve outcomes for women with cardiovascular disease and/or menopause by providing educational interventions designed to enhance the recognition, diagnosis, and management of these conditions.

Day one of the symposium will delve into emerging and under-recognized risk factors for heart disease in women, while addressing gender-related disparities in care. Expert speakers will discuss a broad spectrum of topics, including the diagnosis, management, and cutting-edge treatment of heart failure, cardiovascular disease, cardiac arrhythmias, and cardiomyopathies in women. Day two will shift focus to menopause, exploring the complex hormonal changes that occur during this transitional phase. Specialists from various fields, including cardiology, oncology, urology, neurology, and endocrinology, will examine how menopause impacts the female body and the associated conditions that may arise.

Objectives:
Upon completion of this activity, participants should be able to:

1. Identify cardiovascular disease, conditions and risk factors which are more common and/or unique to women.
2. Analyze the underutilization of guideline-recommended medical and device therapies in women compared to men.
3. Examine the work up and management of heart failure and cardiomyopathy with the unique risks associated with women.
4. Increase proficiency in preventing and reducing cardiovascular disease (CVD) risk by effectively managing key factors such as hypertension (HTN), hyperlipidemia (HL), and menopause.
5. Recognize and discuss symptoms prevalent during each stage of menopause.
6. Summarize the effects of menopause on cardiovascular risk and the role of hormone replacement therapy.
7. Gain confidence in managing obesity through patient counseling and the appropriate use of medical therapies for affected populations.
8. Individualize care for menopausal people with various chronic health conditions.